According to the new report from BCC Research, the projected U.S. market for biodefense-related rapid pathogen detection devices is valued at $214.2 million in 2015. The total market is projected to grow at a compound annual growth rate (CAGR) of 8% from 2016 through 2021 and reach $248 million by 2016 and $364 million by 2021.
Wellesley, Mass. (PRWEB) August 14, 2015
Demand for point-of-use devices will accelerate the growth of handheld devices in the U.S. market for biodefense-related rapid pathogen identification and treatments. BCC Research reveals in its new report that the majority of devices used for rapid detection are handheld readers with the ability to read various assays, either by individual pathogen or with several pathogens in one test.
The U.S. market for rapid identification/sensing products is projected to grow from $248 billion in 2016 to $364 billion in 2021, reflecting a five-year compound annual growth rate of 8%.
Sourced through Scoop.it from: www.benzinga.com